SINOMED, NUI Galway to test new stenting assessment method
The PIONEER IV clinical trial will recruit up to 2,540 patients suffering from any type of coronary heart…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Jul 21
The PIONEER IV clinical trial will recruit up to 2,540 patients suffering from any type of coronary heart…
02 Jul 21
FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart…
30 Jun 21
The DEFINE AFib study will use data collected from the LINQ family of insertable cardiac monitors
30 Jun 21
The next generation Impella RP is claimed to be the first single-access temporary percutaneous ventricular support device with…
29 Jun 21
The device is an implantable cardiac detection monitor and patient-warning system for acute coronary syndrome events
25 Jun 21
The company currently holds an equity interest of up to 27% in Farapulse
24 Jun 21
The UK was an early adopter of 3D heart scans, but uptake in the US is increasing as…
23 Jun 21
The DEFINE GPS study will evaluate the effect of guidance by iFR measurements co-registered on the angiogram in…
22 Jun 21
VNA Care to offer home telemonitoring with SmartHeart technology to transform care and improve clinical outcomes
22 Jun 21
The company will use the funding to scale its commercial reach, expand operational capabilities and strategic partnerships, and…